Alimera Sciences: Schnelle +25% für NBC-Anleger! Im No Brainer Club (NBC) jagt mal wieder ein Erfolg den Nächsten. So konnten Mitglieder des Anlegerclubs mit Alimera Sciences…
ANI Pharmaceuticals, Inc. Completes Acquisition of Alimera Sciences PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today…
ANI Pharmaceuticals Initiates Closing of Acquisition of Alimera Sciences PRINCETON, N.J., Sept. 16, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (“ANI” or the “Company”) announced…
ANI Pharmaceuticals Provides Update on Closing of Acquisition of Alimera Sciences PRINCETON, N.J., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or “the Company”) (Nasdaq: ANIP) today…
ALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. New York, July 27, 2024 (GLOBE NEWSWIRE) -- NEW YORK, July 27, 2024 / GlobeNewswire/-- Monteverde & Associates…
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc. – ALIM NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Monteverde & Associates PC (the “M&A Class Action Firm”), has…
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates Alnylam Pharmaceuticals (ALNY) and Alimera Sciences, Inc. (ALIM) are in the spotlight following study and merger updates, respectively.…
ANI Pharmaceuticals to Further Expand Rare Disease Business through Acquisition of Alimera Sciences Conference call scheduled for today at 8:30 a.m. ET…